Metastatic Breast Cancer

Metastatic Breast Cancer

Expert Perspectives® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics in HR+/HER2- Metastatic Breast Cancer Treatment

expert perspectives
By Joanne Mortimer, MD, FACP, FASCO; David Rimm, MD, PhD; Sagar D. Sardesai, MBBS

HR+ HER2- Breast Cancer

HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies

expert roundtables
By Susan Dent, MD; Matthew P. Goetz, MD; Joseph A. Sparano, MD, FACP

HR+ HER2- Breast Cancer

Extending Overall Survival in HR+/HER2- Advanced Breast Cancer

expert roundtables
By Susan Dent, MD; Matthew P. Goetz, MD; Joseph A. Sparano, MD, FACP

HR+ HER2- Breast Cancer

Preserving Health-Related Quality of Life in Patients With Advanced Breast Cancer

expert roundtables
By Susan Dent, MD; Matthew P. Goetz, MD; Joseph A. Sparano, MD, FACP

HR+ HER2- Breast Cancer

Treatment Approaches in Premenopausal Women With Advanced HR+ Breast Cancer

patient care perspectives
By Joseph A. Sparano, MD, FACP